The Philippines will resume administering AstraZeneca's Covid-19 vaccine to people below 60 years of age, health officials said, ending a temporary suspension over reports of rare blood clots in younger recipients overseas.

“The benefit outweighs the risk. Only a small percentage of the population had these adverse effects for AstraZeneca,” Health Undersecretary Maria Rosario Vergeire told a regular news conference, referring to countries where blood clots were reported.

Health authorities will release guidelines to include different precautions on the use of the AstraZeneca shots, Vergeire added.